drugset
drugset / Trial / NCT06149767

Clinical Study of Adebrelimab Combined With Concurrent Chemoradiotherapy in Cervical Cancer

NCT06149767 ↗

Phase 2 Not yet recruiting 26 enrolled Fujian Cancer Hospital
NaSingle-groupOpen-labelTreatment

Summary

Prospective single-arm clinical study of adebrelimab combined with concurrent chemoradiotherapy in locally advanced cervical cancer

Timeline

Start
2024-01
Primary completion
2028-02
Completion
2028-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Adebrelimab Monoclonal antibody 20 mg/kg Intravenous

Indications

cervical cancer